Table 3.
Frequency | Percent | Valid percent | Cumulative percent | ||
---|---|---|---|---|---|
ACE2 Valid | Infancy | 0 | 0% | 0% | 0% |
Childhood | 9 | 12.85% | 12.85% | 12.85% | |
Adolescence | 13 | 18.57% | 18.57% | 18.57% | |
Adult | 48 | 68.57% | 68.57% | 68.57% | |
Total | 70 | 100% | 100% | 100% | |
ANPEP Valid | Infancy | 0 | 0% | 0% | 0% |
Childhood | 9 | 12.85% | 12.85% | 12.85% | |
Adolescence | 13 | 18.57% | 18.57% | 18.57% | |
Adult | 48 | 68.57% | 68.57% | 68.57% | |
Total | 70 | 100% | 100% | 100% | |
EGFR Valid | Infancy | 0 | 0% | 0% | 0% |
Childhood | 9 | 12.85% | 12.85% | 12.85% | |
Adolescence | 12 | 17.39% | 17.39% | 17.39% | |
Adult | 48 | 68.57% | 68.57% | 68.57% | |
Total | 69 | 99% | 99% | 99% | |
IGF2R Valid | Infancy | 0 | 0% | 0% | 0% |
Childhood | 9 | 12.85% | 12.85% | 12.85% | |
Adolescence | 13 | 18.84% | 18.84% | 18.84% | |
Adult | 47 | 68.11% | 68.11% | 68.11% | |
Total | 69 | 99% | 99% | 99% |